It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
-
The Role of Scientific Advisers in the English Patents Court
-
Trying to Make Sense of the Oracle of G 2/21: T 116/18 vs. T 681/21
-
Patent case: NanoString Technologies vs. 10x Genomics and President and Fellows of Harvard College, UPC
-
Patent case: Judgment no. 141/2023 dated 5 December 2023, Spain
Random Articles:
-
Unified Patent Court will start operating within a year
-
Protection improved for license agreements by recently submitted bill in Germany
-
António Campinos elected next EPO President
-
Early UK elections, delay for the Unitary Patent system?
-
The “Italian torpedo” never ending saga
-
Patent case: Kundendatenbank, Germany
-
Again on MA filing as a preparatory act of marketing – The Court of Turin on Art. 68 (1bis) IP Code
-
EPO: J12/14, European Patent Office, Board of Appeal, 27 March 2015
-
Escitalopram Revisited – Federal Patent Court Rules in Favor of Validity of SPC for Enantiomer over Earlier Marketing Authorization for Racemate
-
Vitreo v. Bulgarian Patent Office, Supreme Administrative Court (Върховен Административен Съд), 25 January 2010